Search
Menu
Home
Sources
About
Contacts
Rivoglitazone
Rivoglitazone
is a
thiazolidinedione
derivative
undergoing
research
for use in the
treatment
of
type 2 diabetes
.
It is being developed by
Daiichi Sankyo
.